Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I S Misko

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Virology|March 14, 1998
Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine designS A Thomson, S R Burrows, I S Misko, et al.
International Journal of Cancer|September 15, 1990
Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cellsI S Misko, C Schmidt, N Martin, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
Virology|August 1, 1989
Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virusT B Sculley, A Apolloni, R Stumm, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune diseaseI S Misko, S M Cross, R Khanna, et al.
Immunology and Cell Biology|February 1, 1989
T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cellsI S Misko, S R Burrows, C Schmidt, et al.
International Immunology|January 7, 1998
Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infectionS L Silins, S M Cross, S L Elliott, et al.
Clinical and Experimental Immunology|January 1, 1992
Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigenI S Misko, C Schmidt, M Honeyman, et al.
Immunology|November 1, 1991
Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cellsR Khanna, C A Jacob, S R Burrows, et al.
The Journal of Experimental Medicine|July 1, 1992
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine developmentR Khanna, S R Burrows, M G Kurilla, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Virology|March 14, 1998
Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine designS A Thomson, S R Burrows, I S Misko, et al.
International Journal of Cancer|September 15, 1990
Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cellsI S Misko, C Schmidt, N Martin, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
Virology|August 1, 1989
Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virusT B Sculley, A Apolloni, R Stumm, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune diseaseI S Misko, S M Cross, R Khanna, et al.
Immunology and Cell Biology|February 1, 1989
T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cellsI S Misko, S R Burrows, C Schmidt, et al.
International Immunology|January 7, 1998
Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infectionS L Silins, S M Cross, S L Elliott, et al.
Clinical and Experimental Immunology|January 1, 1992
Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigenI S Misko, C Schmidt, M Honeyman, et al.
Immunology|November 1, 1991
Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cellsR Khanna, C A Jacob, S R Burrows, et al.
The Journal of Experimental Medicine|July 1, 1992
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine developmentR Khanna, S R Burrows, M G Kurilla, et al.
Pageof 4